Scout | NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)

This grant opportunity supports early-stage, exploratory research in cancer field, focusing on diagnosis, treatment, imaging, symptom/toxicity, and prevention. It encourages new approaches in clinical trials, including developing novel cancer therapies and preclinical studies using innovative models and imaging technologies. The goal is to promote high-risk, high-reward projects that could lea…

Source

Agency: National Institutes of Health

Program: SBIR

Award

Award Ceiling: $275,000

Funding Amount: $275,000

Dates

Submission Deadline: July 1, 2025

Application Window Closes: July 1, 2025

Opportunity Released: July 14, 2022

Open for Submission: July 14, 2022

Keywords

cancer research

clinical trials

exploratory research

radiotherapy development

novel therapeutics

preclinical studies

imaging technologies

symptom management

toxicity prevention

NCI grants

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers